Conditions: Healthy Subjects
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 516
Healthy volunteers: no

Brief summary:
This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution

Detailed description:
Central Cornea Endothelial Cell Counts will be done on a subset of approximately 150 subjects to complete 100 subjects as part of the safety measures.

Arms:
arm 1: 1 drop in each eye 3 times daily for up to 6 weeks arm 2: 1 drop in each eye 3 times daily for up to 6 weeks

Interventions: intervention 1: AC-170 0.24% intervention 2: AC-170 Vehicle
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: